In esophageal squamous cell carcinoma, tumor cells activate the STAT3 pathway on NK cells through IL6 and IL8, leading to down-regulation of NKp30 and NKG2D on NK cells and tumor progression (215) (Figure 3). Here, KLRK1 is linked to neoplasm.